Audiological and temporal bone findings in myxedema

Area of Science:

• Otolaryngology
• Endocrinology
• Pathology

Background:

• Myxedema, a condition caused by hypothyroidism, can affect various bodily systems.
• Previous assumptions suggested a potential link between myxedema and hearing impairment.
• The impact of thyroid hormone replacement on auditory function in myxedema patients requires clarification.

Purpose of the Study:

• To investigate the effect of levothyroxine treatment on hearing sensitivity in patients with myxedema.
• To determine if myxedema is associated with hearing loss compared to the general population.
• To examine temporal bone histology for myxedema-related structural changes.

Main Methods:

• Audiological evaluations were conducted before and after levothyroxine treatment in 15 myxedema patients.
• A separate group of 13 elderly myxedema patients on long-term treatment underwent reexamination.
• Histological analysis of temporal bones from one myxedema patient was performed.

Main Results:

• No significant improvement in hearing sensitivity was observed in either younger or elderly myxedema patients post-treatment.
• Myxedema patients showed no difference in hearing loss compared to age- and sex-matched controls.
• Temporal bone histology revealed no morphological changes or glycosaminoglycan deposition attributable to myxedema.

Conclusions:

• Levothyroxine treatment does not improve hearing sensitivity in myxedema patients.
• Myxedema is not associated with hearing impairment, nor does it cause demonstrable structural changes in the temporal bone.